Skip to main content
. 2011 Feb 23;32(5):772–778. doi: 10.1093/carcin/bgr036

Table I.

Correlation of miR-145 expression levels with p53 status and miR-145 methylation in tumor and adjacent normal tissues

Samples miR-145 expression Met-T (%) Met-N (%) dMet (T-N) p53 mutation
1 0.224 98 60 38 S241F
2 0.087 78 60 18 N288Y
3 0.141 71 26 45 C242S
4 0.744 80 75 5 R175P
5 1.316 69 67 2
6 0.192 87 60 27 Y236N
7 0.103 93 58 35 M246L
8 0.694 88 64 24
9 0.130 87 83 4
10 0.938 86 81 5
11 1.038 76 71 5
12 0.913 93 82 11
13 0.276 86 62 24 S240G
14 0.191 83 79 4 A119T
15 0.061 83 60 23
16 0.407 77 69 8
17 0.375 74 58 16 C242Y
18 0.008 85 63 22
19 0.163 86 60 26 Q104E
20 0.326 77 73 4
21 0.658 89 76 13 R273S

Low miR-145 expression was arbitrarily defined as smaller than 0.75 (standardized by adjacent normal) and indicated in bold. Methylation (%) in tumor (T) and adjacent normal (N) was the average of percentages at six CpG sites. dMethylation was the difference between methylation in cancer and adjacent normal. Values >20 were considered to represent significantly higher methylation and shown in bold. p53 mutations are indicated with codon number and names of involved amino acids.